[
  {
    "date": "2023-09-29",
    "symbol": "AVXL",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2023-09-30",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2023,
    "currentfiscalyearenddate": "--09-30",
    "entityfilenumber": "001-37606",
    "entityregistrantname": "ANAVEX LIFE SCIENCES CORP.",
    "entitycentralindexkey": 1314052,
    "entitytaxidentificationnumber": "98-0608404",
    "entityincorporationstatecountrycode": "NV",
    "entityaddressaddressline1": "630 5th Avenue",
    "entityaddressaddressline2": "20th Floor",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY",
    "entityaddresscountry": "US",
    "entityaddresspostalzipcode": 10111,
    "cityareacode": 844,
    "localphonenumber": "689-3939",
    "security12btitle": "Common     Stock, $0.001 par value",
    "tradingsymbol": "AVXL",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "true",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorname": "GRANT THORNTON LLP",
    "auditorlocation": "Melville, New York",
    "auditorfirmid": 248,
    "cashandcashequivalentsatcarryingvalue": 151024000,
    "incometaxesreceivable": 2709000,
    "prepaidexpenseandotherassetscurrent": 653000,
    "assets": 154386000,
    "accountspayablecurrent": 4322000,
    "accruedliabilitiescurrent": 7295000,
    "deferredrentcredit": 917000,
    "liabilities": 12534000,
    "commonstockvalue": 82000,
    "additionalpaidincapitalcommonstock": 434839000,
    "retainedearningsaccumulateddeficit": -293069000,
    "stockholdersequity": 141852000,
    "liabilitiesandstockholdersequity": 154386000,
    "preferredstocksharesauthorized": 10000000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesissued": 82066511,
    "commonstocksharesoutstanding": 82066511,
    "generalandadministrativeexpense": 12039000,
    "researchanddevelopmentexpense": 43717000,
    "operatingexpenses": 55756000,
    "operatingincomeloss": -55756000,
    "nonoperatingincomefromgrants": 25000,
    "researchanddevelopmentincentiveincome": 2718000,
    "interestincomeexpensenet": 6519000,
    "otherfinancingexpense": 964000,
    "foreigncurrencytransactiongainlossbeforetax": -40000,
    "nonoperatingincomeexpense": 8258000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -47498000,
    "currentincometaxexpensebenefit": 7000,
    "netincomeloss": -47505000,
    "earningspersharebasic": -0.6,
    "earningspersharediluted": -0.6,
    "weightedaveragenumberofsharesoutstandingbasic": 79787596,
    "weightedaveragenumberofdilutedsharesoutstanding": 79787596,
    "noncashfinancingrelatedcharges": 845000,
    "sharebasedcompensation": 16370000,
    "increasedecreaseinincometaxesreceivable": -484000,
    "increasedecreaseinprepaidexpense": 299000,
    "increasedecreaseinaccountspayable": 497000,
    "increasedecreaseinaccruedliabilities": 1350000,
    "deferredgrantincome": -473000,
    "netcashprovidedbyusedinoperatingactivities": -27785000,
    "proceedsfromissuanceofcommonstock": 27875000,
    "proceedsfromstockoptionsexercised": 1776000,
    "netcashprovidedbyusedinfinancingactivities": 29651000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 1866000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 151024000,
    "cashpaidforstateandlocalminimumincometaxes": 136000,
    "sharesoutstanding": 82066511,
    "sharesissuedunder2023purchaseagreementinitialcommitmentshares": 845000,
    "sharesissuedunder2023purchaseagreementinitialcommitmentsharesshares": 75000,
    "stockrepurchasedduringperiodvalue": 3000,
    "stockrepurchasedduringperiodshares": 3275000,
    "commitmentsharesshares": 13943,
    "sharesissuedpursuanttoexerciseofstockoptions": 1000,
    "sharesissuedpursuanttoexerciseofstockoptionsshares": 759753,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 16370000,
    "cashfdicinsuredamount": 250000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 14271780,
    "accruedclinicalsiteandpatientvisitscosts": 2006000,
    "accruedbonusescurrent": 1360000,
    "fixedcontractaccruals": 38000,
    "milestonebasedcontractaccruals": 1267000,
    "otheraccruedliabilitiescurrent": 2624000,
    "grantincome": 500000,
    "researchanddevelopmentarrangementcontracttoperformforotherscompensationearned": 2700000,
    "nonoperatingincomefromgrant": 25000,
    "deferredgrantincome1": 900000,
    "otherreceivables": 2500000,
    "percentageofgrossproceedsfromsales": 0.03,
    "salesofagreementamount": 142400000,
    "stockissuedduringperiodsharesnewissues": 3288943,
    "fairvalueofinitialcommitment": 800000,
    "incurredexpenses": 100000,
    "stockissuedduringperiodvaluenewissues": 27900000,
    "stockissuedduringperiodvalueother": 122100000,
    "operatingleasecost": 118000,
    "pensioncontributions": 232000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 150000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 3.17,
    "warrantsandrightsoutstandingmaturitydate": "2024-05-06",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 14111780,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 7.12,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 5.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 22290069,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1959000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 9.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 257083,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 12,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexercisesprice": 6.74,
    "stockissuedduringperiodsharesstockoptionsexercised": 759753,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.34,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexercisesprice": 0.95,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 4629026,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 9604614,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 5.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 3.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 22290069,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 0.92,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P4Y8M26D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 3280309,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 2.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.037,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y7M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8513,
    "operatingleaseweightedaverageremainingleaseterm1": "P12M",
    "classofwarrantorrightoutstanding": 160000,
    "warrantsoutstandingweightedaverageexercise": 3.72,
    "commonstockcapitalsharesreservedforfutureissuance": 6050553,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesauthorized": 6000000,
    "optionissued": 3849917,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 6661535,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 3.94,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "P4Y9M",
    "allocatedsharebasedcompensationexpense": 16400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 14100000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -41198000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -6300000,
    "deferredtaxassetsoperatinglosscarryforwards": 46462000,
    "deferredtaxassetsinprocessresearchanddevelopment": 2713000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 18593000,
    "deferredtaxassetsresearchanddevelopmentcapitalization": 7219000,
    "deferredtaxassetsunpaidcharges": 1559000,
    "deferredtaxassetsgoodwillandintangibleassets": 593000,
    "deferredtaxassetsunrealizedcurrencylosses": 49000,
    "deferredtaxassetsvaluationallowance": 77188000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -9975000,
    "permanentdifferencesrelatingtostockbasedcompensation": -601000,
    "effectiveincometaxratereconciliationgiltiamount": 165000,
    "incometaxreconciliationotheradjustments": 273000,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopmentcreditnet": -37000,
    "incometaxreconciliationstateandlocalincometaxes": -4122000,
    "incometaxreconciliationprioryearincometaxes": 206000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 14098000,
    "deferredincometaxexpensebenefit": 7000,
    "operatinglosscarryforwards": 126300000,
    "operatinglosscarryforwardsdescription": "$37.7 million will begin to expire in 2025 and $88.6 million can be carried forward indefinitely",
    "operatinglosscarryforwardsexpirationyear": 2036,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": 2700000,
    "researchanddevelopmenttaxcreditsyear": 2029,
    "deferredtaxassetsgross": 7200000
  },
  {
    "date": "2022-09-29",
    "symbol": "AVXL",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2022-09-30",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2022,
    "currentfiscalyearenddate": "--09-30",
    "entityfilenumber": "001-37606",
    "entityregistrantname": "ANAVEX LIFE SCIENCES CORP.",
    "entitycentralindexkey": 1314052,
    "entitytaxidentificationnumber": "98-0608404",
    "entityincorporationstatecountrycode": "NV",
    "entityaddressaddressline1": "630 5th Avenue",
    "entityaddressaddressline2": "20th Floor",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY",
    "entityaddresscountry": "US",
    "entityaddresspostalzipcode": 10111,
    "cityareacode": 844,
    "localphonenumber": "689-3939",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "true",
    "auditorname": "GRANT THORNTON LLP",
    "auditorlocation": "Hartford, Connecticut",
    "auditorfirmid": 248,
    "cashandcashequivalentsatcarryingvalue": 149157861,
    "incometaxesreceivable": 3192580,
    "prepaidexpenseandotherassetscurrent": 354162,
    "assets": 152704603,
    "accountspayablecurrent": 3824777,
    "accruedliabilitiescurrent": 5944953,
    "deferredrentcredit": 443831,
    "liabilities": 10213561,
    "commonstockvalue": 77944,
    "additionalpaidincapitalcommonstock": 387976881,
    "retainedearningsaccumulateddeficit": -245563783,
    "stockholdersequity": 142491042,
    "liabilitiesandstockholdersequity": 152704603,
    "preferredstocksharesauthorized": 10000000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesissued": 77942815,
    "commonstocksharesoutstanding": 77942815,
    "generalandadministrativeexpense": 13070068,
    "researchanddevelopmentexpense": 37915747,
    "operatingexpenses": -50985815,
    "operatingincomeloss": -50985815,
    "researchanddevelopmentincentiveincome": 3323011,
    "interestincomeexpensenet": 946988,
    "foreigncurrencytransactiongainlossbeforetax": -903611,
    "nonoperatingincomeexpense": 3366388,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -47619427,
    "currentincometaxexpensebenefit": 358492,
    "netlossandcomprehensiveloss": -47977919,
    "netlosspersharebasicanddiluted": -0.62,
    "weightedaveragenumberofsharesoutstandingbasicanddiluted": 76909993,
    "netincomeloss": -47977919,
    "sharebasedcompensation": 18379242,
    "increasedecreaseinincometaxesreceivable": -5944251,
    "increasedecreaseinprepaidexpense": -1387,
    "increasedecreaseinaccountspayable": -915004,
    "increasedecreaseinaccruedliabilities": 330179,
    "netcashprovidedbyusedinoperatingactivities": -24237864,
    "proceedsfromissuanceofcommonstock": 20984667,
    "paymentsofstockissuancecosts": 706877,
    "proceedsfromstockoptionsexercised": 1010190,
    "netcashprovidedbyusedinfinancingactivities": 21287980,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -2949884,
    "cash": 149157861,
    "cashpaidforstateandlocalminimumincometaxes": 326903,
    "sharesoutstanding": 77942815,
    "sharesissuedpursuanttoexerciseofstockoptions": 401,
    "sharesissuedpursuanttoexerciseofstockoptionsinshares": 400537,
    "sharesissuedundersalesagreement": 1623,
    "sharesissuedundersalesagreementinshares": 1623813,
    "lessshareissuecosts": -723242,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 18379242,
    "cashfdicinsuredamount": 250000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 13329616,
    "clinicalsitecostsandpatientvisits": 2031105,
    "accruedbonusescurrent": 1297337,
    "fixedcontractaccruals": 417414,
    "otheraccruedliabilitiescurrent": 2199097,
    "researchanddevelopmentarrangementcontracttoperformforotherscompensationearned": 3323011,
    "deferredgrantincome": 443831,
    "percentageofgrossproceedsfromsales": 0.03,
    "saleofstocknumberofsharesissuedintransaction": 1623813,
    "grossproceedsfromissuancepublicoffering": 20984667,
    "proceedsfromissuanceinitialpublicoffering": 20261425,
    "salesofagreementamount": 142407882,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 160000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageexerciseprice": 3.72,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsforfeituresandexpirations": 50000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsweightedaverageexercisepriceforfeited": 12,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 150000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 3.17,
    "warrantsandrightsoutstandingmaturitydate": "2024-05-06",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 13169616,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 62267309,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2358000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 10.13,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 7.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 118750,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 6.86,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexercisesprice": 5.23,
    "stockissuedduringperiodsharesstockoptionsexercised": 400537,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.52,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexercisesprice": 1.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 4201015,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 8777113,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 4.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 55173997,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 0.92,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 2.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P5Y1M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 3883345,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 2.3,
    "allocatedsharebasedcompensationexpense": 18379242,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0311,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y6M25D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8417,
    "leaseandrentalexpense": 72865,
    "pensioncontributions": 158112,
    "commonstockcapitalsharesreservedforfutureissuance": 6050553,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesauthorized": 6000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 406453,
    "optionissued": 2058000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 8363453,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 4.69,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "P5Y1M6D",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 19032000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -40001893,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -7617534,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -47619427,
    "deferredtaxassetsoperatinglosscarryforwards": 46208000,
    "deferredtaxassetsinprocessresearchanddevelopment": 2182000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 13373000,
    "deferredtaxassetsunpaidcharges": 894000,
    "deferredtaxassetsgoodwillandintangibleassets": 388000,
    "deferredtaxassetsunrealizedcurrencylosses": 44000,
    "deferredtaxassetsvaluationallowance": 63089000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -10000000,
    "incometaxreconciliationforeignincometaxratedifferential": -170000,
    "permanentdifferencesrelatingtostockbasedcompensation": -714000,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopmentcreditnet": 232000,
    "incometaxreconciliationstateandlocalincometaxes": -4975000,
    "incometaxreconciliationprioryearincometaxes": 24000,
    "taxesexcludingincomeandexcisetaxes": 358492,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 15603000,
    "deferredincometaxexpensebenefit": 358492,
    "operatinglosscarryforwards": 123400000,
    "operatinglosscarryforwardsdescription": "$37.7 million will begin to expire in2025 and $85.7 million can be carried forward indefinitely",
    "operatinglosscarryforwardsexpirationyear": 2036,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": 2200000,
    "valuationallowancedeferredtaxassetchangeinamount": 3300000
  },
  {
    "date": "2021-09-29",
    "symbol": "AVXL",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2021-09-30",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2021,
    "currentfiscalyearenddate": "--09-30",
    "entityfilenumber": "001-37606",
    "entityregistrantname": "ANAVEX LIFE SCIENCES CORP.",
    "entitycentralindexkey": 1314052,
    "entitytaxidentificationnumber": "98-0608404",
    "entityincorporationstatecountrycode": "NV",
    "entityaddressaddressline1": "630 5th Avenue",
    "entityaddressaddressline2": "20th Floor",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY",
    "entityaddresscountry": "US",
    "entityaddresspostalzipcode": 10111,
    "cityareacode": 844,
    "localphonenumber": "689-3939",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "true",
    "cashandcashequivalentsatcarryingvalue": 152107745,
    "incometaxesreceivable": 9136831,
    "prepaidexpensecurrent": 355549,
    "unamortizedlossreacquireddebtnoncurrent": 16365,
    "assets": 161616490,
    "accountspayablecurrent": 4739781,
    "accruedliabilitiescurrent": 5614774,
    "deferredrentcredit": 443831,
    "liabilities": 10798386,
    "commonstockvalue": 75920,
    "additionalpaidincapitalcommonstock": 348328048,
    "retainedearningsaccumulateddeficit": -197585864,
    "stockholdersequity": 150818104,
    "liabilitiesandstockholdersequity": 161616490,
    "preferredstocksharesauthorized": 10000000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesissued": 75918465,
    "commonstocksharesoutstanding": 75918465,
    "generalandadministrativeexpense": 9017511,
    "researchanddevelopmentexpense": 32983674,
    "operatingexpenses": 42001185,
    "nonoperatingincomefromgrants": 54100,
    "researchanddevelopmentincentiveincome": 4547099,
    "interestincomeexpensenet": 26261,
    "foreigncurrencytransactiongainlossbeforetax": -267344,
    "nonoperatingincomeexpense": 4360116,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -37641069,
    "currentincometaxexpensebenefit": 267565,
    "netlossandcomprehensiveloss": -37908634,
    "earningspersharebasicanddiluted": -0.54,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 69802960,
    "netincomeloss": -37908634,
    "sharebasedcompensation": 8231403,
    "increasedecreaseinincometaxesreceivable": 4287491,
    "increasedecreaseinprepaidexpense": -88290,
    "increasedecreaseinaccountspayable": 750727,
    "increasedecreaseinaccruedliabilities": 2298200,
    "deferredgrantincome": -443831,
    "netcashprovidedbyusedinoperatingactivities": -30383674,
    "proceedsfromissuanceofcommonstock": 153218762,
    "paymentsofstockissuancecosts": 5550921,
    "proceedsfromwarrantexercises": 1466500,
    "proceedsfromstockoptionsexercised": 4108060,
    "netcashprovidedbyusedinfinancingactivities": 153242401,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 122858727,
    "cash": 152107745,
    "cashpaidforstateandlocalminimumincometaxes": 139531,
    "sharesoutstanding": 75918465,
    "stockissuedduringperiodvalueacquisitions": 4008,
    "stockissuedduringperiodsharesacquisitions": 4007996,
    "commitmentsharesissuedsharesundertermsofpurchaseagreement2": 78,
    "commitmentsharesissuedvalueundertermsofpurchaseagreement1": 78213,
    "sharesissuedpursuanttoexerciseofstockoptions": 1421,
    "sharesissuedpursuanttoexerciseofstockoptionsinshares": 1421529,
    "sharesissuedpursuanttoregistereddirectofferingnetofshareissuecosts": 2381,
    "sharesissuedpursuanttoregistereddirectofferingnetofshareissuecostsinshares": 2380953,
    "sharesissuedpusuanttoexerciseofwarrants": 350,
    "sharesissuedpusuanttoexerciseofwarrantsinshares": 350000,
    "sharesissuedduringperiodvalueundersalesagreement": 5635,
    "sharesissuedduringperiodsharesundersalesagreement": 5634576,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 8231403,
    "cashfdicinsuredamount": 250000,
    "incrementalcommonsharesattributabletocalloptionsandwarrants": 11540903,
    "clinicalsitecostsandpatientvisits": 2035800,
    "accruedbonusescurrent": 1201903,
    "fixedcontractaccruals": 649649,
    "otheraccruedliabilitiescurrent": 1727422,
    "researchanddevelopmentarrangementcontracttoperformforotherscompensationearned": 497931,
    "nonoperatingincomefromgrant": 54100,
    "otherincome": 443831,
    "stockissuedduringperiodsharesnewissues": 5634576,
    "grossproceedsfromsaleofcommonstock": 79107550,
    "proceedsfromissuanceinitialpublicoffering": 76670027,
    "percentageofgrossproceedsfromsales": 0.03,
    "salesofagreementamount": 163392550,
    "stockissuedduringperiodsharesnewissues4": 4007996,
    "stockissuedduringperiodvaluenewissues3": 24111198,
    "stockissuedduringperiodsharesnewissues3": 78213,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 210000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageexerciseprice": 5.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantinperiod": 60000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantedinperiodweightedaverageexpiredprice": 12,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercised": 350000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsweightedaverageexercisepriceexercised": 4.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 150000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 3.17,
    "warrantsandrightsoutstandingmaturitydate": "2024-05-06",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 11330903,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 5.74,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 140132451,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2732000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 12.55,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 9.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 55834,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 3.04,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexercisesprice": 2.43,
    "stockissuedduringperiodsharesstockoptionsexercised": 1421529,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.89,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexercisesprice": 2.43,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 24446305,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 7228488,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 3.73,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 102786851,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 0.92,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 2.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y3M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 3167682,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 2.1,
    "allocatedsharebasedcompensationexpense": 8231403,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0073,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y8M26D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9343,
    "leaseandrentalexpense": 130784,
    "pensioncontributions": 128856,
    "commonstockcapitalsharesreservedforfutureissuance": 6050553,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 146371,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesauthorized": 6000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 2.54,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "P5Y6M3D",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 21650000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -28850926,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -8790143,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -37641069,
    "deferredtaxassetsoperatinglosscarryforwards": 34982000,
    "deferredtaxassetsinprocessresearchanddevelopment": 1577000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 10453000,
    "deferredtaxassetsunpaidcharges": 89000,
    "deferredtaxassetsgoodwillandintangibleassets": 323000,
    "deferredtaxassetsunrealizedcurrencylosses": 62000,
    "deferredtaxassetsvaluationallowance": 47486000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -7934000,
    "incometaxreconciliationforeignincometaxratedifferential": -353000,
    "permanentdifferencesrelatingtostockbasedcompensation": -4379000,
    "permanentdifferencesrelatingtosection162m": 816000,
    "incometaxreconciliationotheradjustments": 741000,
    "adjustmenttotaxassetsbasedonsection382": 3330000,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopmentcreditnet": 1042000,
    "incometaxreconciliationstateandlocalincometaxes": -7022000,
    "incometaxreconciliationprioryearincometaxes": 48000,
    "effectofexchangerateoncash": 216000,
    "taxesexcludingincomeandexcisetaxes": 267565,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 13495000,
    "deferredincometaxexpensebenefit": 267565,
    "operatinglosscarryforwards": 101600000,
    "operatinglosscarryforwardsdescription": "$37.7 will begin to expire in 2025 and $63.9 can be carried forward indefinitely",
    "operatinglosscarryforwardsexpirationyear": 2036,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": 1600000,
    "valuationallowancedeferredtaxassetchangeinamount": 3300
  },
  {
    "date": "2020-09-29",
    "symbol": "AVXL",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2020-09-30",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2020,
    "currentfiscalyearenddate": "--09-30",
    "entityfilenumber": "001-37606",
    "entityregistrantname": "ANAVEX LIFE SCIENCES CORP.",
    "entitycentralindexkey": 1314052,
    "entitytaxidentificationnumber": "98-0608404",
    "entityincorporationstatecountrycode": "NV",
    "entityaddressaddressline1": "51 W 52nd Street",
    "entityaddressaddressline2": "7th Floor",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY",
    "entityaddresscountry": "US",
    "entityaddresspostalzipcode": 10019,
    "cityareacode": 844,
    "localphonenumber": "689-3939",
    "security12btitle": "Common     Stock, $0.001 par value",
    "tradingsymbol": "AVXL",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "cashandcashequivalentsatcarryingvalue": 29249018,
    "incometaxesreceivable": 4849340,
    "prepaidexpensecurrent": 443839,
    "assets": 34542197,
    "accountspayablecurrent": 3989054,
    "accruedliabilitiescurrent": 3316574,
    "liabilities": 7305628,
    "commonstockvalue": 62047,
    "additionalpaidincapitalcommonstock": 186851752,
    "retainedearningsaccumulateddeficit": -159677230,
    "stockholdersequity": 27236569,
    "liabilitiesandstockholdersequity": 34542197,
    "preferredstocksharesauthorized": 10000000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 100000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesissued": 62045198,
    "commonstocksharesoutstanding": 62045198,
    "generalandadministrativeexpense": 5856609,
    "researchanddevelopmentexpense": 25231623,
    "operatingexpenses": 31088232,
    "nonoperatingincomefromgrant": 149888,
    "researchanddevelopmentincentiveincome": 4375025,
    "interestincomeexpensenet": 179973,
    "foreigncurrencytransactiongainlossbeforetax": 125540,
    "nonoperatingincomeexpense": 4830426,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -26257806,
    "currentincometaxexpensebenefit": 22664,
    "netincomeloss": -26280470,
    "earningspersharebasicanddiluted": -0.45,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 58194894,
    "sharebasedcompensation": 4876906,
    "increasedecreaseinincometaxesreceivable": 2206595,
    "increasedecreaseinprepaidexpense": -57159,
    "increasedecreaseinaccountspayable": 465722,
    "increasedecreaseinaccruedliabilities": 1800232,
    "netcashprovidedbyusedinoperatingactivities": -21287046,
    "proceedsfromissuanceofcommonstock": 28754198,
    "paymentsofstockissuancecosts": 403764,
    "netcashprovidedbyusedinfinancingactivities": 28350434,
    "cashandcashequivalentsperiodincreasedecrease": 7063388,
    "cash": 29249018,
    "sharesoutstanding": 62045198,
    "stockissuedduringperiodvalueacquisitions": 7565,
    "stockissuedduringperiodsharesacquisitions": 7564584,
    "commitmentsharesissuedsharesundertermsofpurchaseagreement1": 69,
    "commitmentsharesissuedvalueundertermsofpurchaseagreement1": 68943,
    "sharesissuedpursuanttocashlessexerciseofoptions": 1,
    "sharesissuedpursuanttocashlessexerciseofoptionsinshares": 721,
    "sharesissuedduringperiodvalueundersalesagreement": 1760,
    "sharesissuedduringperiodsharesundersalesagreement": 1760429,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 4876906,
    "cashrefundavailabledescription": "The cash refund is available to eligiblecompanies with an annual aggregate revenue of less than $20.0 million Australian during the reimbursable period.",
    "incrementalcommonsharesattributabletocalloptionsandwarrants": 10576266,
    "researchanddevelopmentarrangementcontracttoperformforotherscompensationearned": 4375025,
    "stockissuedduringperiodsharesnewissues": 12016457,
    "stockissuedduringperiodsharesnewissues4": 7564584,
    "stockissuedduringperiodvaluenewissues3": 21254298,
    "stockissuedduringperiodsharesnewissues3": 68943,
    "percentageofgrossproceedsfromsales": 0.1999,
    "stockissuedduringperiodvaluenewissues4": 24111197,
    "numberofstocksold": 1760429,
    "grossproceedsfromsaleofcommonstock": 7499900,
    "numberofsharesavailable": 42500100,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageexerciseprice": 3.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantinperiod": 150000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantedinperiodweightedaverageexpiredprice": 3.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 350000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 4.19,
    "warrantsandrightsoutstandingmaturitydate": "2021-06-30",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 10076266,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 14982581,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1695000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 68332,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 3.01,
    "stockissuedduringperiodsharesstockoptionsexercised": 13335,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 3.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 7412100,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 3.66,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 10763906,
    "allocatedsharebasedcompensationexpense": 4876906,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0157,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y6M10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9599,
    "leaseandrentalexpense": 233423,
    "sharesissuedpursuanttocashlessexerciseofwarrantinshares": 4938,
    "stockissuedpursuanttocashlessexerciseofwarrants": 8750,
    "commonstockcapitalsharesreservedforfutureissuance": 6050553,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 146371,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesauthorized": 6000000,
    "sharesissuedpursuanttocashlessexercisesofoption": 721,
    "numberofcashlessexerciseoption": 13335,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 4040812,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -18096148,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -8161658,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -26257806,
    "deferredtaxassetsoperatinglosscarryforwards": 23397000,
    "deferredtaxassetsinprocessresearchanddevelopment": 2069000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 8283000,
    "deferredtaxassetsunpaidcharges": 83000,
    "deferredtaxassetsgoodwillandintangibleassets": 132000,
    "deferredtaxassetsunrealizedcurrencylosses": 27000,
    "deferredtaxassetsvaluationallowance": 33991000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -5519000,
    "incometaxreconciliationforeignincometaxratedifferential": -723000,
    "incometaxreconciliationotheradjustments": 35000,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopmentcreditbenefit": 1267000,
    "incometaxreconciliationstateandlocalincometaxes": -2911000,
    "incometaxreconciliationprioryearincometaxes": 373000,
    "effectofexchangerateoncash": 36000,
    "taxesexcludingincomeandexcisetaxes": 22664,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 7442000,
    "deferredincometaxexpensebenefit": 22664,
    "deferredtaxassetsoperatinglosscarryforwardsforeign": 76800000,
    "operatinglosscarryforwardsexpirationyear1": 2027,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 103100000,
    "operatinglosscarryforwards": 4300000
  },
  {
    "date": "2019-09-29",
    "symbol": "AVXL",
    "period": "FY",
    "entityregistrantname": "ANAVEX LIFE SCIENCES CORP.",
    "entitycentralindexkey": 1314052,
    "documenttype": "10-K",
    "documentperiodenddate": "2019-09-30",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--09-30",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityshellcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "NV",
    "entityfilenumber": "001-37606",
    "entityfilercategory": "Accelerated Filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2019,
    "cashandcashequivalentsatcarryingvalue": 22185630,
    "incometaxesreceivable": 2642745,
    "prepaidexpenseandotherassetscurrent": 500998,
    "assetscurrent": 25329373,
    "assets": 25329373,
    "accountspayablecurrent": 3523332,
    "accruedliabilitiescurrent": 1516342,
    "liabilitiescurrent": 5039674,
    "commonstockvalue": 52652,
    "additionalpaidincapitalcommonstock": 153633807,
    "retainedearningsaccumulateddeficit": -133396760,
    "stockholdersequity": -133396760,
    "liabilitiesandstockholdersequity": 25329373,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 52650251,
    "commonstocksharesoutstanding": 52650521,
    "generalandadministrativeexpense": 6846599,
    "researchanddevelopmentexpense": 22260349,
    "operatingexpenses": 29106948,
    "nonoperatingincomefromgrant": 298943,
    "researchanddevelopmentincentiveincome": 250000,
    "interestincomeexpensenet": 207280,
    "gainslossesonrestructuringofdebt": 115758,
    "debtrelatedcommitmentfeesanddebtissuancecosts": 151133,
    "foreigncurrencytransactiongainlossbeforetax": -42389,
    "nonoperatingincomeexpense": 2894150,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -26212798,
    "currentincometaxexpensebenefit": 82181,
    "netincomeloss": -26294979,
    "earningspersharebasicanddiluted": -0.54,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 48906470,
    "sharebasedcompensation": 6430873,
    "deferredcharges": 151133,
    "increasedecreaseinotherreceivables": 772388,
    "increasedecreaseinprepaidexpense": -803196,
    "increasedecreaseinaccountspayable": 683797,
    "increasedecreaseinaccruedliabilities": 587009,
    "netcashprovidedbyusedinoperatingactivities": -18527117,
    "proceedsfromissuanceofcommonstock": 17832109,
    "paymentsofdebtissuancecosts": 50000,
    "netcashprovidedbyusedinfinancingactivities": 17782109,
    "cashperiodincreasedecrease": -745008,
    "stockissuedduringperiodvalueacquisitions": 13192755,
    "stockissuedduringperiodsharesacquisitions": 4848995,
    "commitmentsharesissuedsharesundertermsofpurchaseagreement": -24,
    "commitmentsharesissuedvalueundertermsofpurchaseagreement": 23701,
    "stockissuedduringperiodvalueacquisitions1": 4633005,
    "stockissuedduringperiodsharesacquisitions1": 1500000,
    "commitmentsharesissuedsharesundertermsofpurchaseagreement1": -339,
    "commitmentsharesissuedvalueundertermsofpurchaseagreement1": 339415,
    "sharesissuedpursuanttocashlessexerciseofwarrants": -5,
    "sharesissuedpursuanttocashlessexerciseofwarrantsinshares": 4938,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 6430873,
    "incrementalcommonsharesattributabletocalloptionsandwarrants": 8812933,
    "stockissuedduringperiodsharesnewissues": 1839415,
    "stockissuedduringperiodsharesnewissues4": 1500000,
    "stockissuedduringperiodvaluenewissues3": 4634505,
    "stockissuedduringperiodsharesnewissues3": 339415,
    "stockissuedduringperiodvaluenewissues4": 45365495,
    "percentageofgrossproceedsfromsales": 0.03,
    "legalfees": 151133,
    "initialcommitmentshares": 324383,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 350000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsexercisedinperiod": -8750,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsexpiredinperiod": -319629,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageexerciseprice": 4.19,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsexercisedinperiodweightedaverageexerciseprice": 1.13,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsexercisedinperiodweightedaverageexpiredprice": 1.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 8462933,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2265399,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 309383,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 5727963,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.58,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.79,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 3.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 3.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 4115032,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 3275500,
    "allocatedsharebasedcompensationexpense": 3227708,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.025,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.0445,
    "leaseandrentalexpense": 190416,
    "warrantsoutstanding": 350000,
    "shareprice": 4.19,
    "stockissuedpursuanttocashlessexerciseofwarrants": 8750,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesauthorized": 6000000,
    "commonstockcapitalsharesreservedforfutureissuance": 6050553,
    "remainingallocatedsharebasedcompensationexpense": 5097281,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "The exercise price will be determined by the board of directors at the time of grant shall be at least equal to the fair market value on such date. If the grantee is a 10% stockholder on the grant date, then the exercise price shall not be less than 110% of fair market value of the Company&#8217;s shares of common stock on the grant date.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -18031016,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -8181782,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -26212798,
    "deferredtaxassetsoperatinglosscarryforwards": 18704000,
    "deferredtaxassetsinprocessresearchanddevelopment": 1162000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 6570000,
    "deferredtaxassetsunpaidcharges": 69000,
    "deferredtaxassetsgoodwillandintangibleassets": 30000,
    "deferredtaxassetsunrealizedcurrencylosses": 15000,
    "deferredtaxassetsvaluationallowance": 26551000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -5505000,
    "incometaxreconciliationforeignincometaxratedifferential": -825000,
    "incometaxreconciliationotheradjustments": 140000,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopmentcreditbenefit": 914000,
    "incometaxreconciliationprioryearincometaxes": 194000,
    "taxesexcludingincomeandexcisetaxes": 82181,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 5082000,
    "deferredincometaxexpensebenefit": 82181,
    "deferredtaxassetsoperatinglosscarryforwardsforeign": 60800000,
    "deferredtaxassetsotherlosscarryforwards": 64000000,
    "operatinglosscarryforwards": 5200000,
    "operatinglosscarryforwardsexpirationyear1": 2027,
    "effectiveincometaxratereconciliationstateandlocalincometaxesprevious": 0.35,
    "effectiveincometaxratereconciliationstateandlocalincometaxesrevised": 0.21,
    "deferredtaxassetsvaluationallowancecurrent": 3900000
  }
]